help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serri, O.
Right arrow Articles by Renier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serri, O.
Right arrow Articles by Renier, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 2 979-985
Copyright © 2004 by The Endocrine Society

Enhanced Lipoprotein Lipase Secretion and Foam Cell Formation by Macrophages of Patients with Growth Hormone Deficiency: Possible Contribution to Increased Risk of Atherogenesis?

Omar Serri, Ling Li, Fritz Maingrette, Nicolas Jaffry and Geneviève Renier

Centre Hospitalier de l’Université de Montréal Research Centre, Notre-Dame Hospital, and Department of Nutrition, University of Montreal, Montreal, Canada H2L 4M1

Address all correspondence and requests for reprints to: Dr. Geneviève Renier, Centre Hospitalier de l’Université de Montréal Research Centre, Notre-Dame Hospital, 3rd floor, J. A. de Sève, Y-3622, 1560 Sherbrooke Street East, Montreal, Québec, Canada H2L 4M1. E-mail: genevieve.renier{at}umontreal.ca.

GH deficiency is associated with increased prevalence of atherosclerosis, and recent data indicate a proatherogenic role for macrophage lipoprotein lipase (LPL) in the arterial wall. In this pilot study, we determined LPL expression and foam cell formation in monocyte-derived macrophages of 12 control subjects and nine patients with GH deficiency without GH replacement therapy. LPL mRNA levels, mass, and activity were increased in macrophages of patients with GH deficiency. In these subjects, macrophage LPL activity correlated with body mass index and fat mass. Incubation of patient macrophages with IGF-I for 24 h or differentiation of monocytes isolated from GH-deficient patients into macrophages in the presence of this growth factor decreased the amount of LPL mass. Compared with control cells, macrophages derived from GH-deficient patients took up and stored increased amounts of proatherogenic lipoproteins and were more easily converted to foam cells. In the supernatants of these cells, increased levels of free fatty acids and TNF{alpha} were also documented. These results demonstrate that macrophages of patients with GH deficiency secrete increased amounts of proatherogenic cytokines and are more susceptible to foam cell formation. These alterations may contribute to the increased cardiovascular risk in patients with GH deficiency.

This work was supported in part by Eli Lilly.

Abbreviations: BMI, Body mass index; Dil, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LDL, low-density lipoprotein; LPL, lipoprotein lipase; oxLDL, oxidized LDL.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Colao, C. Di Somma, F. Rota, R. Pivonello, M. C. Savanelli, S. Spiezia, and G. Lombardi
Short-Term Effects of Growth Hormone (GH) Treatment or Deprivation on Cardiovascular Risk Parameters and Intima-Media Thickness at Carotid Arteries in Patients with Severe GH Deficiency
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2056 - 2062.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Conti, C. Carrozza, E. Capoluongo, M. Volpe, F. Crea, C. Zuppi, and F. Andreotti
Insulin-Like Growth Factor-1 as a Vascular Protective Factor
Circulation, October 12, 2004; 110(15): 2260 - 2265.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society